Zobrazeno 1 - 10
of 30
pro vyhledávání: '"B. Saparova"'
Autor:
A. N. Afanaseva, V. B. Saparova, I. E. Makarenko, T. A. Selmenskikh, D. V. Kurkin, A. L. Hohlov, R. V. Drai
Publikováno v:
Разработка и регистрация лекарственных средств, Vol 13, Iss 1, Pp 247-255 (2024)
Introduction. Romiplostim is an analogue of the fusion protein peptide of thrombopoietin (TPO), which increases platelet count by binding and activating the human thrombopoietin receptor (TPO-R). It is used to treat thrombocytopenia associated with c
Externí odkaz:
https://doaj.org/article/b275653dfe8748d792b2e41f4c5157b3
Autor:
D. V. Kurkin, D. A. Bakulin, E. I. Morkovin, V. I. Petrov, A. V. Strygin, K. N. Koryanova, Yu. V. Gorbunova, Yu. A. Kolosov, O. V. Ivanova, E. V. Pavlova, M. A. Dzhavakhyan, A. V. Zaborovsky, V. B. Saparova, I. E. Makarenko, R. I. Drai, A. N. Chumachenko
Publikováno v:
Фармация и фармакология (Пятигорск), Vol 11, Iss 4, Pp 347-380 (2024)
Modern approaches to the treatment of type 2 diabetes mellitus (T2DM) are aimed not only at glycemic control, but also at reducing cardiovascular risks. The increasing prevalence of the disease and the need for effective treatment options highlight t
Externí odkaz:
https://doaj.org/article/95f6d86f77b4438484e0b9ff432b4ee0
Autor:
A. V. Babina, R. V. Drai, V. B. Saparova, A. N. Afanasyeva, P. G. Zaikin, V. I. Shmurak, T. E. Eltysheva, I. E. Makarenko
Publikováno v:
Разработка и регистрация лекарственных средств, Vol 12, Iss 2, Pp 124-134 (2023)
Introduction. Currently, biosimilars have found quite widespread use in the treatment of a number of chronic and life-threatening diseases. Thanks to them, there is a significant decrease of the economic pressure of biological drugs on the health car
Externí odkaz:
https://doaj.org/article/786a8dd4fc784d75aae394661378ffa3
Autor:
D. V. Kurkin, D. A. Bakulin, E. I. Morkovin, A. V. Strygin, Yu. V. Gorbunova, E. V. Volotova, I. E. Makarenko, V. B. Saparova, R. V. Drai, V. I. Petrov
Publikováno v:
Фармация и фармакология (Пятигорск), Vol 11, Iss 1, Pp 19-47 (2023)
Modern requirements for the treatment of type 2 diabetes mellitus (DM2) include not only achieving a glycemic control, but also reducing the risk of developing cardiovascular complications. Dipeptidyl peptidase 4 (DPP-4) inhibitors are inferior in th
Externí odkaz:
https://doaj.org/article/f0fe50a3b67f4dd0bc0505b700df9935
Publikováno v:
Регуляторные исследования и экспертиза лекарственных средств, Vol 13, Iss 1, Pp 77-88 (2023)
Russian and international regulatory documents require that analytical procedures for establishing bioequivalence and comparability of quality attributes of biotechnological (biological) products, carrying out batch release of medicinal products, and
Externí odkaz:
https://doaj.org/article/d6fd7359d73b4bbc8d3817c970259007
Autor:
A. N. Afanasyeva, V. B. Saparova, D. D. Karal-Ogly, E. I. Mukhametzyanova, D. V. Kurkin, A. V. Kalatanova, I. E. Makarenko, A. L. Khokhlov, I. A. Lugovik
Publikováno v:
Фармация и фармакология (Пятигорск), Vol 10, Iss 4, Pp 354-370 (2022)
Idiopathic thrombocytopenic purpura is a chronic autoimmune hematological disease caused by an increased destruction of platelets and associated thrombocytopenia, for the treatment of which the imported drug romiplostim is used. Сreation of the drug
Externí odkaz:
https://doaj.org/article/a5cc49ccab96497c88981a4904fcda8c
Autor:
B. Saparova
Publikováno v:
BULLETIN OF THE KARAGANDA UNIVERSITY. ECONOMY SERIES. 107:181-186
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8907d94825109228c73c54297f1a4f21
https://doi.org/10.31489/2022ec3/181-186
https://doi.org/10.31489/2022ec3/181-186
Autor:
D. V Kurkin, E. I Morkovin, D. A Bakulin, Yu. V Gorbunova, A. V Strygin, A. I Robertus, I. E Makarenko, V. B Saparova, R. V Drai, V. I Petrov
Publikováno v:
Journal of Volgograd State Medical University. 19:34-49
Resume. In Russia, type 2 diabetes affects more than 5 % of the population. Type 2 diabetes accounts for up to 95 % of all cases of diabetes meUitus, but its pathogenetic mechanisms have not yet been fully established. Aim. To summarize and analyze t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f3868bc740a2a2d025178ea036c110f6
https://doi.org/10.19163/1994-9480-2022-19-4-34-49
https://doi.org/10.19163/1994-9480-2022-19-4-34-49
Publikováno v:
THE BULLETIN. 2:44-49
The article justifies for the need to identify and to keep track, in practice, of different groups of risks inherent in educational institutions under current conditions of pandemic and post-pandemic transformation of education under the influence of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::323f550d8d79758016502d521e26f102
https://doi.org/10.32014/2021.2518-1467.
https://doi.org/10.32014/2021.2518-1467.
Autor:
Anna N. Arefeva, Igor E. Makarenko, Valeria B. Saparova, Dzhina D. Karal-ogli, Alina N. Afanaseva, Artem R. Dorotenko, Anna V. Kalatanova, Denis V. Kurkin, Alexandr L. Khokhlov, Roman V. Drai
Publikováno v:
Biologicals. 81:101666
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::115acf3e3dc2099bc941d72cd2ca5c64
https://doi.org/10.1016/j.biologicals.2023.101666
https://doi.org/10.1016/j.biologicals.2023.101666